Yahoo FinanceThree Day Seminar on Veterinary Drug Approval Process and FDA Regulatory Oversight (October 20-22, 2021)
Dublin, Aug. 11, 2021 (GLOBE NEWSWIRE) -- The "The Veterinary Drug Approval Process and FDA Regulatory Oversight" training has been added to ResearchAndMarkets.com's offering.
The U.S. Food and Drug Administration's Center for Veterinary Medicine (CVM) is responsible for the approval of veterinary drug products intended for family pets, food-producing animals, and other animal species.
This seminar will cover the process for obtaining federal government approval for marketing new animal drug products that are under the jurisdiction of the FDA, and also briefly covers animal products that are regulated by other federal agencies.
For example, animal vaccines, animal disease diagnostic devices and some animal biologics are regulated by the U.S. Department of Agriculture, and some flea and tick control products are regulated by the Environmental Protection Agency.
This three-day interactive seminar will provide attendees with an understanding of FDA's veterinary drug approval process. The group size is small, generally between 8 and 20 people, with plenty of opportunities to ask questions and discuss issues or challenges that the attendees have experienced.
Learning Objectives:
How the U.S. Food and Drug Administration (FDA) regulates animal drug products.
How FDA's Center for Veterinary Medicine is organized.
The process by which veterinary drug products are reviewed and approved.
How to open an Investigational New Animal Drug (INAD) File.
The FDA's various user fees, what fee waivers are available, and how to request a fee waiver.
The various technical sections included in a New Animal Drug Application (NADA).
What information is needed to substantiate product characterization, target animal safety and effectiveness.
An overview of FDA's rules governing chemistry, manufacturing and controls (CMC).
The various components of an animal field study to support product approval.
How animal feed, veterinary devices, OTC drug products and nutritional supplements are regulated in the U.S.
Key Topics Covered:
Day 01 (9:00 AM to 1:00 PM PDT)
Introduction to the Veterinary Drug Approval Process
Definitions
INAD/NADA technical sections
Some differences between human and animal drug approval process
FDA organization and jurisdiction
FDA Centers relevant to Animal Health
Introduction to Federal Regulations (FD&CA, AMDUCA, ADAA, FDAMA)
FDA Guidance documents and other online resources
Discovery/Acquisition - Preliminary Patent Protection Concerns
INAD/NADA Phased Review
Open an INAD File
Submit Early Information
Phased Review of Technical Sections
Meetings with CVM
Brief description of cGxP (GMP, GLP, GCP)
Day 02 (9:00 AM to 1:00 PM PDT)
Developing the NADA Technical Sections
Chemistry, Manufacturing, Controls (CMC)
Effectiveness
The 7 Major Phases of Clinical Field Studies
Target Animal Safety (TAS)
Human Food Safety
Environmental Impact
Labeling
Freedom of Information (FOI) Summary
All Other Information (AOI)
Overview of Generic Animal Drugs (JINAD)
Submissions - ANADA sections
CMC
Bioequivalence (Safety & Efficacy)
Human Food Safety
Labeling
Day 03 (9:00 AM to 1:00 PM PDT)
Minor Use Minor Species (MUMS)
Designation
Indexing
Marketing Exclusivity & Exclusive Marketing Rights
Animal Drug User Fees and related waivers
Animal Feed, OTC Drugs, Supplements, Medical Devices
Animal health products regulated by USDA & EPA
Non-Approval-Related Considerations
Extra-Label Drug Use
Compounding
Noncompliance and Enforcement
Pharmacovigilance
Post-approval submissions for CMC changes
Review of the Typical Steps in Veterinary Drug Development
For more information about this training visit https://www.researchandmarkets.com/r/v7pa85
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
